Inventor

Chih-Hung Lee

Inventor

Vernon Hills, IL, US

Overview

2001–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 71 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%

C07DHeterocyclic compounds26%

A61KPreparations for medical, dental or toiletry purposes12%

C07CAcyclic or carbocyclic compounds5%

H03FAmplifiers3%

G01NInvestigating or analysing materials by determining their chemical or physical properties2%

H04BTransmission2%

H04WWireless communication networks2%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%

H03LAutomatic control, starting, synchronisation or stabilisation of generators of electronic oscillations or pulses2%

PatentTitleYear

10,717,168Glass treatment apparatus and methods of treating glass2020 10,707,773Energy acquisition and power supply system2020 10,601,013Composite film and manufacturing method for the same and battery comprising composite film2020 10,412,482Loudspeaker apparatus2019 10,088,868Portable electronic device for acustic imaging and operating method for the same2018 9,983,218Indole and indoline derivatives and methods of use thereof2018 9,712,973'Method of selecting a SIM for a location service and multi-SIM device utilizing the same'2017 9,625,475'Indole and indoline derivatives and methods of use thereof'2017 9,385,683'Diplexer and transceiver thereof'2016 9,374,697'Method of selecting an active SIM for an emergency service and multi-SIM device utilizing the same'2016 9,257,725'Separator for lithium cells having porous and cured layers on a non-woven support'2016 9,186,407'Pharmaceutical compositions and their methods of use'2015 9,100,083'Radio-frequency front-end supporting multiple wireless communication standards'2015 9,063,126'Indole and indoline derivatives and methods of use thereof'2015 9,040,568'Pharmaceutical compositions for the treatment of pain'2015 8,987,453'Azaadamantane derivatives and methods of use'2015 8,954,114'Apparatuses and methods for providing multi-standby mode of wireless communications using single subscriber identity card with multiple subscriber numbers'2015 8,940,762'Methods for treating pain'2015 8,853,241'Biaryl substituted azabicyclic alkane derivatives'2014 8,815,930'Compounds that inhibit TRPV1 and uses thereof'2014 8,802,711'TRPV1 antagonists'2014 8,778,959'AZA-bridged ring-fused indoles and indolines'2014 8,755,841'Apparatuses and methods for providing multi-standby mode of wireless communications using single subscriber identity card with multiple subscriber numbers'2014 8,598,220'Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof'2013 8,593,207'Limiting amplifiers'2013 8,536,221'Amide derivatives as positive allosteric modulators and methods of use thereof'2013 8,524,703'Bridgehead amine ring-fused indoles and indolines'2013 8,501,769'Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof'2013 8,487,116'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'2013 8,486,979'1,2,4 oxadiazole compounds and methods of use thereof'2013 8,440,691'Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof'2013 8,395,452'Signal amplification circuits for receiving/transmitting signals according to input signal'2013 8,383,658'Isoxazole based neuronal nicotinic receptor ligands and methods of use'2013 8,350,083'Antagonists of the TRPV1 receptor and uses thereof'2013 8,314,119'Azaadamantane derivatives and methods of use'2012 8,310,314'Signal amplification circuits for receiving/transmitting signals according to input signal'2012 8,268,853'3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof'2012 8,247,413'Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'2012 8,232,309'Prodrugs of compounds that inhibit TRPV1 receptor'2012 8,076,350'Spirocyclic azaadamantane derivatives and methods of use'2011 8,071,762'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'2011 8,030,504'Antagonists of the TRPV1 receptor and uses thereof'2011 8,026,256'Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor'2011 7,994,223'Amide derivatives as positive allosteric modulators and methods of use thereof'2011 7,983,361'Clock data recovery circuit'2011 7,965,108'Frequency synthesizer'2011 7,902,236'Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof'2011 7,902,900'Limiting amplifiers'2011 7,902,222'Biaryl substituted azabicyclic alkane derivatives'2011 7,875,627'Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof'2011 7,812,019'Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof'2010 7,786,171'Amide derivatives as positive allosteric modulators and methods of use thereof'2010 7,767,705'Compounds that inhibit TRPV1 and uses thereof'2010 7,636,003'Limiting amplifiers'2009 7,622,493'Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof'2009 7,615,570'Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof'2009 7,605,667'Frequency synthesizer with a harmonic locked phase/frequency detector'2009 7,595,332'Amides that inhibit vanilloid receptor subtype 1 (VR1)'2009 7,504,520'Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof'2009 7,375,126'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'2008 7,354,955'(2S)-amino(phenyl)acetic acid and derivatives as Î±2Î´ voltage-gated calcium channel ligands'2008 7,348,343'Amides useful for treating pain'2008 7,335,678'Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor'2008 7,129,235'Amides useful for treating pain'2006 7,074,805'Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'2006 7,037,927'Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor'2006 7,015,233'Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor'2006 6,933,311'Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'2005 6,831,193'Trisubstituted-N-(1S)-1,2,3,4-Tetrahydro-1-naphthalenylbenzamides which inhibit P2X3 and P2X2/3 containing receptors'2004 6,693,136'Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptors'2004 6,304,224'Adapter for antenna on a mobile phone'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2020Based in Taipei, TW· patent location history

2004–2013Patents assigned to ABBOTT LAB (30)· patent assignee history

2004–2018Based in Vernon Hills, IL, US· patent location history

2009–2017Patents assigned to MEDIATEK INC (14)· patent assignee history

2009–2020Based in Chiayi County, TW· patent location history

2011–2017Patents assigned to LEE CHIH-HUNG (28)· patent assignee history

2011–2017Patents assigned to LI TAO (11)· patent assignee history

2012–2018Patents assigned to ABBVIE INC (20)· patent assignee history

2014–2020Based in Kaohsiung, TW· patent location history

2018–2019Based in Taichung, TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ABBOTT LAB	30	2004–2013
LEE CHIH-HUNGself	28	2011–2017
ABBVIE INC	20	2012–2018
MEDIATEK INC	14	2009–2017
LI TAO	11	2011–2017

Locations

Location	Patents	Span
Vernon Hills, Illinois, US	50	2004–2018
Chiayi County, TW	11	2009–2020
Kaohsiung, TW	5	2014–2020
Taipei, TW	3	2001–2020
Taichung, TW	2	2018–2019